Breath test for tuberculosis
Nur Hazlinda K, Roza S, Izzuna MM
Record ID 32018014788
English
Authors' objectives:
The objective of this technology review was to assess the accuracy,
effectiveness, safety, and economic implication of breath test in diagnosing
tuberculosis in patients suspected of having TB.
Authors' results and conclusions:
Efficacy/ effectiveness
There was fair level of retrievable evidence on breath test showing its varying performance in diagnosing tuberculosis.
Breath test (electronic nose)
Breath test using electronic nose showed good pooled diagnostic accuracy.
However, the performance of electronic nose was varied in four diagnostic
accuracy studies included in this review. Sensitivity and specificity ranging
from 52.3% to 90.8% and 36.4% to 99% respectively. The studies included in this review varies in terms of type of electronic nose used and population tested.
Breath test (other than electronic nose)
The performance of breath test other than electronic nose was good in
diagnosing TB with sensitivity and specificity ranging from 80.4% to 95.7% and 80.3% to 91.3% respectively, and AUC performance ranged from 0.867 to 0.935.
Safety
There was limited evidence retrieved on the safety of breath test. Breath tests was not associated with treatment-related adverse events during the
sessions or the follow-up. The United States Food and Drug Administration (US FDA) has not yet approved breath testing for tuberculosis. The electronic nose device is claimed as having CE approval,
indicating compliance with European regulatory standards.
Organisational issues
All the practices regarding the test analysis including the pre-examination,
examination, post- examination, safety and training of staff or operator shall follow international or local guidelines such as Malaysian Standard, MS ISO 15189:2014, Specific Technical Requirement for Accreditation of Medical Microbiology Laboratories (STR 2.5) and National Policy and Guidelines for Point of Care Testing by Ministry of Health Malaysia.
Economic implication
No cost-effectiveness study retrieved on breath test to diagnose
Tuberculosis.
Conclusion
A fair level of retrieved evidences has demonstrated that point-of-care (POC) breath test has moderate to good diagnostic accuracy in detecting TB in high incidence setting.
No safety issue has reported with the use of this device. No cost
effectiveness study retrieved on this device.
Authors' methods:
The following electronic databases were searched through the Ovid
interface: MEDLINE(R) and Epub Ahead of Print, In-Process, In-DataReview & Other Non-Indexed Citations, Daily and Versions 1946 to January 08, 2024, HTA Full-text Journals, EBM Reviews - Cochrane Database of Systematic Reviews 2005 to March 6, 2024, EBM Reviews - ACP Journal Club 1991 to February 2024, EBM Reviews - Cochrane Clinical Answers February 2024, EBM Reviews - Cochrane Central Register of Controlled Trials February 2024. Parallel searches were run in MISR (PubMed), US FDA and INAHTA database while additional articles were retrieved from reviewing the bibliographies of retrieved articles. The search was limited to articles on human. There was no language limitation in the search. The last search was conducted on 13th March 2024. Among the tools used to assess the risk of bias and methodological quality of the articles retrieved is the ROBIS and Critical Appraisal Skill Programme (CASP) cheklist. All full text articles were then graded based on guidelines from the US/Canadian Preventive Services Task Force.
Details
Project Status:
Completed
Year Published:
2024
URL for published report:
https://www.moh.gov.my/index.php/database_stores/store_view_page/30/410
Requestor:
Pathologist
English language abstract:
An English language summary is available
Publication Type:
Mini HTA
Country:
Malaysia
MeSH Terms
- Tuberculosis
- Mass Screening
- Breath Tests
- Tuberculosis, Pulmonary
Keywords
- Tuberculosis
- Breath Test
Contact
Organisation Name:
Malaysian Health Technology Assessment
Contact Address:
Malaysian Health Technology Assessment Section, Ministry of Health Malaysia, Federal Government Administrative Centre, Level 4, Block E1, Parcel E, 62590 Putrajaya Malaysia Tel: +603 8883 1229
Contact Name:
htamalaysia@moh.gov.my
Contact Email:
htamalaysia@moh.gov.my
Copyright:
Malaysian Health Technology Assessment Section (MaHTAS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.